“Primary Outcome Indices In Illicit Drug Dependence Treatment Research: Systematic Approach To Selection And Measurement Of Drug Use End-Points In Clinical Trials.”. Addiction 107 (4). Addiction: 694-708. doi:10.1111/j.1360-0443.2011.03473.x.
. 2012. “Nida Clinical Trials Network Ctn-0051, Extended-Release Naltrexone Vs. Buprenorphine For Opioid Treatment (X:bot): Study Design And Rationale.”. Contemp Clin Trials 50. Contemp Clin Trials: 253-64. doi:10.1016/j.cct.2016.08.004.
. 2016.